SYROS PHARMACEUTICALS INC's ticker is and the CUSIP is 87184Q907. A total of 3 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | -33.3% | 2,300 | -28.1% | 0.00% | – |
| Q1 2022 | $3,000 | -70.0% | 3,200 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | -84.6% | 3,200 | -72.2% | 0.00% | – |
| Q3 2021 | $65,000 | +4.8% | 11,500 | +0.9% | 0.00% | – |
| Q2 2021 | $62,000 | -27.9% | 11,400 | +9727.6% | 0.00% | – |
| Q1 2021 | $86,000 | -73.0% | 116 | -60.5% | 0.00% | – |
| Q4 2020 | $318,000 | +15800.0% | 294 | +9700.0% | 0.00% | – |
| Q3 2020 | $2,000 | -75.0% | 3 | -62.5% | 0.00% | – |
| Q2 2020 | $8,000 | -50.0% | 8 | -71.4% | 0.00% | – |
| Q1 2020 | $16,000 | -11.1% | 28 | +3.7% | 0.00% | – |
| Q4 2019 | $18,000 | +12.5% | 27 | +68.8% | 0.00% | – |
| Q2 2018 | $16,000 | +433.3% | 16 | +300.0% | 0.00% | – |
| Q1 2018 | $3,000 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 13,900 | $151,000 | 0.00% |
| SIMPLEX TRADING, LLC | 294 | $318,000 | 0.00% |